Blood test could spare sarcoma patients from repeated biopsies

NCT ID NCT06958107

First seen Jan 23, 2026 · Last updated May 23, 2026 · Updated 21 times

Summary

This study is testing a blood test called a liquid biopsy to see if it can detect tumor DNA in people with bone or soft tissue sarcoma. Researchers will collect blood samples before, during, and after treatment to track how well the test works. The goal is to find a less invasive way to monitor the cancer. The study is open to people of all ages with suspected or confirmed sarcoma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center

    RECRUITING

    Winston-Salem, North Carolina, 27103, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.